Day One Biopharmaceuticals Inc (DAWN)
Operating Income Growth
57.97%
Quarterly · Period ending:
DAWN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported57.97%period ending
Latest reported57.97%period ending
DAWN Quarterly Operating Income YoY % (-809.33% → 57.97%)
Year-over-year change
High-resolution chart · PNG
DAWN operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 57.9716% | |
| -181.8295% | |
| 69.5367% | |
| 38.4921% | |
| -9.7703% | |
| 157.615% | |
| -133.0917% | |
| -45.6046% | |
| -39.2439% | |
| -29.57% | |
| -34.1376% | |
| -65.2552% | |
| -94.5074% | |
| -106.325% | |
| -137.8328% | |
| -72.4978% | |
| -257.666% | |
| -440.3258% | |
| -568.6444% | |
| -809.3273% |